Nano Superbug Zapper
Revolutionary pocket-size device kills 'super' strains of bacteria and viruses in seconds!more info...
Dr Jonathan Wright
America's 'miracle' medic is now writing exclusively for our readers in the UK. Claim his 6-volume 'Library of Natural Healing' FREE!more info...
SAFETOX - THE NATURAL, NON-TOXIC FACELIFT PHENOMENON
Watch wrinkles fade by 83% with this 5 minute-a-day facelift wondermore info...
NEW! . . . SUPER FOODS FOR A SUPER-HEALTHY YOU
Unleash the secret healing power of Nature's ultimate foods - & 'programme' your body to remain free of illnessmore info...
Healthy Living
How A Big Pharma Cocktail Can Seriosly Damage Your Health
Date: 29/11/11
Keywords: American Food and Drug Administration (FDA), The Cholesterol Truth, adverse side effects, Alternative medicine, drug interactions
Many patients give in to pressure from their doctors to take prescription medicine, when they know alternative remedies are available... and before they know it, they're on a prescription drug roller coaster!
I don't know about you, but this is certainly not a situation I want to find myself in... Sadly, millions of patients do and very soon they're riding the ups and downs of unexpected drug interactions and hideous side effects.
Whilst most doctors will resort to treating these side effects and interactions with more prescription drugs (let's face it, in the world of Big Pharma, drugs are rarely to blame for anything!), many patients don't realise that their kidneys may suffer the most from the over-use of prescription drugs.
Many patients give in to pressure from their doctors to take
prescription medicine, when they know alternative remedies
are available... and before they know it, they're on a
prescription drug roller coaster!
I don't know about you, but this is certainly not a situation I want to find myself in... Sadly, millions of patients do and very soon they're riding the ups and downs of unexpected drug interactions and hideous side effects.
Whilst most doctors will resort to treating these side effects and interactions with more prescription drugs (let's face it, in the world of Big Pharma, drugs are rarely to blame for anything!), many patients don't realise that their kidneys may suffer the most from the over-use of prescription drugs.
Beware of potentially fatal drug interactions
Recently, the American Food and Drug Administration (FDA) warned against a drug linked with kidney damage. The real kicker, is that the side effects of this drug can sometimes be fatal.
The drug, zoledronic acid, goes under the brand names: Zometa, a cancer treatment; and Reclast, a treatment for osteoporosis.
But here's the catch: The warning only applies to patients who already have underlying, moderate-to-severe, kidney impairment...
So, let's say you start out by taking a cholesterol-lowering statin drug (which has a known side effect of acute kidney failure, as reported by the British Medical Journal, in 2010) and you also develop osteoporosis. The next drug your doctor prescribes is Reclast... and voila, your risk of kidney damage dramatically increases!
However, many patients using Reclast will probably think, "Nope. That's not me. No kidney problems here."
Well... don't be fooled... Reclast users, who are also using other prescription drugs, will probably never suspect the various kidney threats that they are exposed to.
Here's another example: Let's say you're one of the thousands of women, post-menopause, who uses a proton pump inhibitor (PPIs like Nexium, Prilosec and Prevacid) to treat heartburn.
Our regular readers will know that PPI drugs increase bone fracture risk and as a post-menopausal woman, you're already at increased risk of fracture. Which means that your doctor may prescribe Reclast... but PPIs are also one of the most common causes of an inflammatory kidney disorder called interstitial nephritis.
One last example: The National Kidney Foundation issued this warning against a drug millions take every day: "NSAIDs [Non-steroidal anti- inflammatory drugs] may cause an increased risk of sudden kidney failure and even progressive kidney damage."
So if you're post-menopausal and you have arthritis, high cholesterol, heartburn, and early signs of osteoporosis, your prescription drug roller- coaster of combined medications could easily put you on track to dialysis — or worse.
Of course, if you'd like to get off this ride, you could eat plenty of unprocessed calcium-rich foods, take daily supplements of calcium and vitamin D, and engage in weight-bearing exercises. These are the safest ways to protect against bone weakness — with no undue stress on the kidneys.
If you'd like to learn more about maintaining a healthy heart, visit our dedicated blog The Cholesterol Truth, by following this link:
Sources:
"FDA Strengthens Kidney Risk Warning for Reclast" Robert Lowes, Medscape, 9/1/11, medscape.com
"Proton pump inhibitors and acute interstitial nephritis" BMJ, Vol. 341, 9/22/10, bmj.com
Back to topI don't know about you, but this is certainly not a situation I want to find myself in... Sadly, millions of patients do and very soon they're riding the ups and downs of unexpected drug interactions and hideous side effects.
Whilst most doctors will resort to treating these side effects and interactions with more prescription drugs (let's face it, in the world of Big Pharma, drugs are rarely to blame for anything!), many patients don't realise that their kidneys may suffer the most from the over-use of prescription drugs.
Beware of potentially fatal drug interactions
Recently, the American Food and Drug Administration (FDA) warned against a drug linked with kidney damage. The real kicker, is that the side effects of this drug can sometimes be fatal.
The drug, zoledronic acid, goes under the brand names: Zometa, a cancer treatment; and Reclast, a treatment for osteoporosis.
But here's the catch: The warning only applies to patients who already have underlying, moderate-to-severe, kidney impairment...
So, let's say you start out by taking a cholesterol-lowering statin drug (which has a known side effect of acute kidney failure, as reported by the British Medical Journal, in 2010) and you also develop osteoporosis. The next drug your doctor prescribes is Reclast... and voila, your risk of kidney damage dramatically increases!
However, many patients using Reclast will probably think, "Nope. That's not me. No kidney problems here."
Well... don't be fooled... Reclast users, who are also using other prescription drugs, will probably never suspect the various kidney threats that they are exposed to.
Here's another example: Let's say you're one of the thousands of women, post-menopause, who uses a proton pump inhibitor (PPIs like Nexium, Prilosec and Prevacid) to treat heartburn.
Our regular readers will know that PPI drugs increase bone fracture risk and as a post-menopausal woman, you're already at increased risk of fracture. Which means that your doctor may prescribe Reclast... but PPIs are also one of the most common causes of an inflammatory kidney disorder called interstitial nephritis.
One last example: The National Kidney Foundation issued this warning against a drug millions take every day: "NSAIDs [Non-steroidal anti- inflammatory drugs] may cause an increased risk of sudden kidney failure and even progressive kidney damage."
So if you're post-menopausal and you have arthritis, high cholesterol, heartburn, and early signs of osteoporosis, your prescription drug roller- coaster of combined medications could easily put you on track to dialysis — or worse.
Of course, if you'd like to get off this ride, you could eat plenty of unprocessed calcium-rich foods, take daily supplements of calcium and vitamin D, and engage in weight-bearing exercises. These are the safest ways to protect against bone weakness — with no undue stress on the kidneys.
If you'd like to learn more about maintaining a healthy heart, visit our dedicated blog The Cholesterol Truth, by following this link:
Sources:
"FDA Strengthens Kidney Risk Warning for Reclast" Robert Lowes, Medscape, 9/1/11, medscape.com
"Proton pump inhibitors and acute interstitial nephritis" BMJ, Vol. 341, 9/22/10, bmj.com
Click here to send to a friendShare thisPrinter friendly version
